Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8(+) T cells
SourceCancer Immunology Immunotherapy, 69, 11, (2020), pp. 2259-2273
Article / Letter to editor
Display more detailsDisplay less details
Cancer Immunology Immunotherapy
SubjectRadboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
AKT-inhibition is a promising approach to improve T cell therapies; however, its effect on CD4(+) T cells is insufficiently explored. Previously, we and others showed that AKT-inhibition during ex vivo CD8(+) T cell expansion facilitates the generation of polyfunctional T cells with stem cell memory-like traits. However, most therapeutic T cell products are generated from lymphocytes, containing CD4(+) T cells that can affect CD8(+) T cells dependent on the Th-subset. Here, we investigated the effect of AKT-inhibition on CD4(+) T cells, during separate as well as total T cell expansions. Interestingly, ex vivo AKT-inhibition preserved the early memory phenotype of CD4(+) T cells based on higher CD62L, CXCR4 and CCR7 expression. However, in the presence of AKT-inhibition, Th-differentiation was skewed toward more Th2-associated at the expense of Th1-associated cells. Importantly, the favorable effect of AKT-inhibition on the functionality of CD8(+) T cells drastically diminished in the presence of CD4(+) T cells. Moreover, also the expansion method influenced the effect of AKT-inhibition on CD8(+) T cells. These findings indicate that the effect of AKT-inhibition on CD8(+) T cells is dependent on cell composition and expansion strategy, where presence of CD4(+) T cells as well as polyclonal stimulation impede the favorable effect of AKT-inhibition.
Upload full text